Reduced inflammation in genetically hypertensive rat airways is associated with reduced tachykinin NK1 receptor numbers

被引:3
|
作者
Campbell, VA
Beddy, P
Foley, A
Bakhle, YS
Bell, C [1 ]
机构
[1] Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland
[2] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, Leukocyte Biol Sect, London, England
关键词
tachykinin NK1 receptor; substance P; inflammation; hypertension genetic; GH (genetically hypertensive) rat; nitric oxide (NO);
D O I
10.1016/S0014-2999(00)00394-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The airways of the genetically hypertensive rat (GH) are hyperinnervated by substance P-containing sensory nerves and exhibit reduced inflammatory responsiveness to substance P and to capsaicin. The present study measured tracheal inflammation to resiniferatoxin (1.0 mu g/kg i.v.), a capsaicin analogue, which lacks the hypotensive action of capsaicin itself, alone or after the neuronal nitric oxide synthase inhibitor 1-(2-trifluoromethylphenyl)imidazole (TRIM) (50 mg/kg i.p.). The inflammatory response to resiniferatoxin alone was 50% lower in untreated GH than in control rats, a similar strain difference to that seen previously with capsaicin. Pre-treatment with TRIM had no effect on inflammation in either strain. Binding kinetics of the tachykinin NK1 receptor antagonist [H-3](S)-1-{2-[3(3,4-dichlorophenyl)-1-(3 -isopropoxyphenylacetyl)piperidin-3-yl]ethyl}-4-phenyl-1-azoniabicyclo[2,2,2,]octane chloride ([H-3]SR140333)-(0.125-16.0 nM) showed 50% reduction of B-max in GH versus control tracheae (74 +/- 13 cf. 165 +/- 26 fmol/mg protein). Our results indicate that the reduced neurogenic inflammatory responsiveness in GH rats can be attributed entirely to reduced tachykinin NK1 receptor numbers. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [1] Basis of reduced neurogenic inflammation in airways of the genetically hypertensive rat
    Campbell, VA
    Beddy, P
    Foley, A
    Bakhle, YS
    Bell, C
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 : 154P - 155P
  • [2] The dual nature of the tachykinin NK1 receptor
    Maggi, CA
    Schwartz, TW
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) : 351 - 355
  • [3] Nonpeptide antagonists of the NK1 tachykinin receptor
    McLean, S
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (04) : 297 - 317
  • [4] TACHYKININ NK1 RECEPTOR SUBTYPES IN THE RAT URINARY-BLADDER
    MEINI, S
    PATACCHINI, R
    MAGGI, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) : 739 - 746
  • [5] Disulfide bridge engineering in the tachykinin NK1 receptor
    Elling, CE
    Raffetseder, U
    Nielsen, SM
    Schwartz, TW
    BIOCHEMISTRY, 2000, 39 (04) : 667 - 675
  • [6] Crystal structure of the human NK1 tachykinin receptor
    Yin, Jie
    Chapman, Karen
    Clark, Lindsay D.
    Shao, Zhenhua
    Borek, Dominika
    Xu, Qingping
    Wang, Junmei
    Rosenbaum, Daniel M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (52) : 13264 - 13269
  • [7] The human tachykinin, NK1 (short form) and tachykinin NK4 receptor:: a reappraisal
    Page, NM
    Bell, NJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 437 (1-2) : 27 - 30
  • [8] Reduced anxiety and stress responses in mice lacking the NK1 receptor
    Heath, MJS
    Santarelli, L
    Debs, PC
    Hen, R
    ANESTHESIOLOGY, 2000, 93 (3A) : U189 - U189
  • [9] Different subtypes of tachykinin NK1 receptor binding sites are present in the rat brain
    Beaujouan, JC
    Saffroy, M
    Torrens, Y
    Glowinski, J
    JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) : 1015 - 1026
  • [10] The tachykinin NK1 receptor is crucial for the development of non-atopic airway inflammation and hyperresponsiveness
    van der Kleij, HPM
    Kraneveld, AD
    Redegeld, FAM
    Gerard, NP
    Morteau, O
    Nijkamp, FP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 476 (03) : 249 - 255